- TREATING ACUTE RESPIRATORY DISTRESS
-
Provided herein are technologies for treating one or more respiratory diseases, disorders or conditions by administering (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole.
- -
-
Paragraph 0265-0266
(2021/09/17)
-
- IMPROVING RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION
-
Provided herein are methods of improving kidney function after renal transplantation comprising administering (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole.
- -
-
-
- SOLID FORMS OF (E)-3-[2-(2-THIENYL)VINYL]-1H-PYRAZOLE
-
The present disclosure provides solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole, compositions thereof, and methods of making and using the same.
- -
-
Paragraph 00332-00333
(2020/10/21)
-
- METHODS AND COMPOSITIONS OF SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
-
The present invention provides compositions and formulations of compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein p, R1, R2 and B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of injuries, conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role. In addition, methods are provided for treating such diseases or diseases starting at a time after the onset of the injury, condition or disease.
- -
-
Paragraph 0409
(2018/02/28)
-
- SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
-
The present invention provides compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein R1, R2 and B are as described generally and n classes and subclasses herein, and additionally provides pharmaceu
- -
-
-